期刊
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
卷 11, 期 1, 页码 37-42出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00041552-200201000-00006
关键词
-
资金
- PHS HHS [KO8, R01] Funding Source: Medline
Renal cell carcinomas account for 80-85% of all primary renal neoplasms. Recent identification of VHL, c-met and TSC as candidate genes mutated in various types of renal carcinomas has greatly enhanced our understanding of the pathogenesis of renal carcinomas and has provided novel therapeutic options for patients with renal cancer. Furthermore, developments in angiogenesis and in tumor immunology have given us additional treatment modalities for cancer patients, especially those with renal cancer. This review highlights the genetic abnormalities seen in renal cell carcinomas and reviews current and future therapeutic options. Curr Opin Nephrol Hypertens 11:37-42. (C) 2002 Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据